Real World Study of Efficacy and Adherence to Subcutaneous Vs. Intravenous Vedolizumab in Patients with Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention (MONITOR Study)
Latest Information Update: 05 Jan 2025
Price :
$35 *
At a glance
- Drugs Vedolizumab (Primary) ; Vedolizumab
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- Acronyms MONITOR
- 02 Jan 2025 New trial record